Skip to main content

MoneyWorks4Me

Aurobindo Pharma informs about analyst meet

06 Jul 2023 Evaluate

Aurobindo Pharma has informed that the officials of the Company will be participating in the following investor / analyst meetings on July 7, 2023. No unpublished price sensitive information (UPSI) is intended to be discussed during the interactions. The schedule of the meeting is enclosed. 

The above information is a part of company’s filings submitted to BSE.